» Articles » PMID: 10348764

Species Differences in the Proportion of Plasma Lipoprotein Lipid Carried by High-density Lipoproteins Influence the Distribution of Free and Liposomal Nystatin in Human, Dog, and Rat Plasma

Overview
Specialty Pharmacology
Date 1999 May 29
PMID 10348764
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was an interspecies comparison of free nystatin (NYS) and liposomal NYS (Nyotran) distribution in plasma. NYS and liposomal NYS at concentrations of 5, 10, and 20 microg of NYS/ml were incubated in human, dog, and rat plasma for 5, 60, and 180 min at 37 degrees C. Following these incubations, plasma samples were separated into their high-density lipoprotein (HDL), triglyceride-rich lipoprotein, low-density lipoprotein, and lipoprotein-deficient plasma (LPDP) fractions by density-gradient ultracentrifugation, and each fraction was assayed for NYS by high-pressure liquid chromatography. Total plasma and lipoprotein cholesterol, triglyceride, and protein concentrations in each human, dog, or rat plasma sample were determined by enzymatic assays. When NYS and liposomal NYS were incubated in human, dog, or rat plasma, the majority of the NYS was recovered in the LPDP fraction. For the 5- and 60-min incubation times for all plasmas measured, a significantly greater percentage of NYS was recovered in the lipoprotein fraction (primarily HDL) following the incubation of liposomal NYS than following the incubation of NYS. There was a significant correlation between the lipoprotein lipid and protein profiles in human, dog, and rat plasmas and the distribution of NYS and liposomal NYS in plasma. In particular, differences in the proportion of plasma lipoprotein cholesterol, triglyceride, and apolar lipids (cholesteryl ester and triglycerides) carried by HDL influenced the distribution of NYS and liposomal NYS within plasmas of different species. These findings suggest that the distribution of NYS among plasma lipoproteins of different species is defined by the proportion of lipid carried by HDL, and this is possibly an important consideration when evaluating the pharmacokinetics, toxicities, and activities of these compounds following administration to different animal species.

Citing Articles

Feeding of a high protein, low carbohydrate diet leads to greater postprandial energy expenditure and fasted n6: n3 fatty acid ratio in lean, adult dogs compared to a moderate protein, moderate carbohydrate diet.

Banton S, Pezzali J, Richards T, Hillyer L, Ma D, Pisco J Transl Anim Sci. 2025; 9:txaf018.

PMID: 40051529 PMC: 11884651. DOI: 10.1093/tas/txaf018.


Diets Differently Regulate Pulmonary Pathogenesis and Immune Signaling in Mice during Acute and Chronic Infection.

Oswal N, Thangavel H, Lizardo K, Dhanyalayam D, Sidrat T, Salgame P Life (Basel). 2023; 13(1).

PMID: 36676177 PMC: 9861969. DOI: 10.3390/life13010228.


A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a....

Hefnawy M, Alanazi M, Al-Hossaini A, Alnasser A, El-Azab A, Bin Jardan Y Molecules. 2023; 28(1).

PMID: 36615272 PMC: 9822280. DOI: 10.3390/molecules28010079.


Development and Validation of a Chiral Liquid Chromatographic Assay for Enantiomeric Separation and Quantification of Verapamil in Rat Plasma: Stereoselective Pharmacokinetic Application.

Mohammed M, Hefnawy M, Al-Majed A, Alrabiah H, Algrain N, Obaidullah A Molecules. 2021; 26(7).

PMID: 33917412 PMC: 8038655. DOI: 10.3390/molecules26072091.


Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.

Martinez M, Mochel J, Neuhoff S, Pade D AAPS J. 2021; 23(3):59.

PMID: 33907906 DOI: 10.1208/s12248-021-00590-0.


References
1.
Wasan K, Conklin J . Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol. Clin Infect Dis. 1997; 24(1):78-80. DOI: 10.1093/clinids/24.1.78. View

2.
Pontani D, Sun D, Brown J, Shahied S, PLESCIA O, SCHAFFNER C . Inhibition of HIV replication by liposomal encapsulated amphotericin B. Antiviral Res. 1989; 11(3):119-25. DOI: 10.1016/0166-3542(89)90023-5. View

3.
Cenni B, Meyer J, Brandt R, Betschart B . The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum. Br J Clin Pharmacol. 1995; 39(5):519-26. PMC: 1365059. DOI: 10.1111/j.1365-2125.1995.tb04489.x. View

4.
Koldin M, Kobayashi G, Brajtburg J, Medoff G . Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits. Antimicrob Agents Chemother. 1985; 28(1):144-5. PMC: 176327. DOI: 10.1128/AAC.28.1.144. View

5.
Rajaram O, FATTERPAKER P, Sreenivasan A . Involvement of binding lipoproteins in the absorption and transport of alpha-tocopherol in the rat. Biochem J. 1974; 140(3):509-16. PMC: 1168029. DOI: 10.1042/bj1400509. View